HRAS Antikörper (AA 82-176)
Kurzübersicht für HRAS Antikörper (AA 82-176) (ABIN7629434)
Target
Alle HRAS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 82-176
-
Verwendungszweck
- V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) Polyclonal Antibody
-
Sequenz
- Phe82~Glu176
-
Produktmerkmale
- The V-Ha-Ras Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.27 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- HRAS (HRas proto-oncogene, GTPase (HRAS))
-
Andere Bezeichnung
- HRAS
-
Gen-ID
- 3265
-
UniProt
- P01112
-
Pathways
- p53 Signalweg, MAPK Signalweg, RTK Signalweg, Fc-epsilon Rezeptor Signalübertragung, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Hepatitis C, Autophagie, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling, BCR Signaling
Target
-